SBIR/STTR Research Award

A Miniature Autoinjector for Multicomponent Drugs and Vaccines

Award identifier 0e4d01ee2cbfbdbc8d75bd361e7d35624a34288027c0758a199c5800f07ca44aAwarding agency Department of Defense · Office for Chemical and Biological Defense

Award amount

$99,962

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Office for Chemical and Biological Defense
Recipient company
CREARE LLC
Proposal award date
2013-05-01
Contract end date
2013-10-31
UEI
JDKYAKDT4TT6
Solicitation number
2013.1
Topic code
CBD13-106

Research abstract

Chemical, biological, or toxin attacks in military and civilian settings are a serious and growing concern. Standard first aid for exposure to many chemical warfare agents and toxins includes the immediate administration of relevant antidotes using an autoinjector. When an attack occurs, prefilled autoinjectors must be immediately available and thus highly portable, and they must be suitable for use by nonmedical personnel. Similarly, rapid distribution and administration of targeted vaccines is critical during a biological outbreak. Storage of drug formulations as separate components within the injector (e.g., a dry medication and a diluent) can significantly extend the shelf life of many medications. Creare proposes to develop a novel miniaturized autoinjector that automatically mixes two or more pre-filled components immediately prior to injection. The drug storage and reconstitution method is based on Creare"s recently patented technology for disposable, pre-filled drug cartridges and is applicable to single-component, dry/wet, liquid/liquid, and multicomponent combinations. In Phase I, we will develop preliminary autoinjector designs and perform laboratory tests of key actuator functions to illustrate the device form and feasibility. In the Option phase, we will develop detailed designs of the actuator mechanisms, and in Phase II we will design, produce, and test prototype autoinjector devices.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.